June 2020
The UK government’s Department for Business, Energy and Industrial Strategy has published a guide to help England-based laboratory and research facilities understand how to work safely during the coronavirus pandemic:
REGISTER VERY SOON for InformaConnect’s free-to-attend Clinical Trials Digital Week from 1-4 June. This global series of live educational webcasts and downloadable resources provides the latest insights for operational challenges and responding to a pandemic, partnerships, outsourcing and operations, technology in clinical trials, and clinical innovation:
“Lessons from the crucible of crisis”, a timely article from Marcia McNutt, president of the U.S. National Academy of Sciences in Washington, DC, USA:
Clinical trials of the Russian-made coronavirus drug favipiravir enter final stage. It is being tested by Russian pharmaceutical investment firm ChemRar with the support of the Russian Direct Investment Fund (RDIF):
According to a report from Reportlinker.com, the global Clinical Laboratory Services market is projected to grow by US$39.9 Billion by 2025, driven by a compounded growth of 5.3%. Hospital-based Laboratories have the potential to grow at over 5%:
Britain should consider deliberately infecting volunteers involved in vaccine-testing projects, which is in line with World Health Organization proposals to set up such human challenge trials. Earlier this month, the WHO issued a 19-page set of guidelines on how these trials might operate:
